[促红细胞生成素在慢性肾功能不全和血液透析患者中的应用]。

Revista medica de Panama Pub Date : 1996-01-01

C J Cuero, E Pérez Guardia, C de Rivera

{"title":"[促红细胞生成素在慢性肾功能不全和血液透析患者中的应用]。","authors":"C J Cuero, E Pérez Guardia, C de Rivera","doi":"","DOIUrl":null,"url":null,"abstract":"Erythropoietin (EP) injected subcutaneously (SC) 2 or 3 times a week, respectively, or intravenously (IV) 3 times a week, increased the hemoglobin and the hematocrit of all the patients so treated. The total units of EP used was less when it was administered SC. EP once or twice a week, respectively, administered SC also increased the hemoglobin and hematocrit in each case, and the total amount of EP used was also less.","PeriodicalId":21235,"journal":{"name":"Revista medica de Panama","volume":"21 1-2","pages":"55-9"},"PeriodicalIF":0.0000,"publicationDate":"1996-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Use of erythropoietin in patients with chronic renal insufficiency and in hemodialysis].\",\"authors\":\"C J Cuero, E Pérez Guardia, C de Rivera\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Erythropoietin (EP) injected subcutaneously (SC) 2 or 3 times a week, respectively, or intravenously (IV) 3 times a week, increased the hemoglobin and the hematocrit of all the patients so treated. The total units of EP used was less when it was administered SC. EP once or twice a week, respectively, administered SC also increased the hemoglobin and hematocrit in each case, and the total amount of EP used was also less.\",\"PeriodicalId\":21235,\"journal\":{\"name\":\"Revista medica de Panama\",\"volume\":\"21 1-2\",\"pages\":\"55-9\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1996-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista medica de Panama\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista medica de Panama","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

皮下注射促红细胞生成素(EP)每周2次或3次，静脉注射促红细胞生成素(EP)每周3次，所有患者的血红蛋白和红细胞压积均升高。每周分别给予1次或2次EP，两组患者的血红蛋白和红细胞压积均有所增加，EP的总用量也较少。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

微信好友朋友圈 QQ好友复制链接

本刊更多论文

[Use of erythropoietin in patients with chronic renal insufficiency and in hemodialysis].

Erythropoietin (EP) injected subcutaneously (SC) 2 or 3 times a week, respectively, or intravenously (IV) 3 times a week, increased the hemoglobin and the hematocrit of all the patients so treated. The total units of EP used was less when it was administered SC. EP once or twice a week, respectively, administered SC also increased the hemoglobin and hematocrit in each case, and the total amount of EP used was also less.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Revista medica de Panama

自引率

0.00%

发文量

期刊最新文献

[Otitis media with effusion]. [Racial mix of the panamanian population]. [Carbon dioxide angiography: technique and indications]. [Atypical testicular masses: a case presentation]. [C0 vs C2 levels and their implications in kidney transplantation].